Teva and Mylan dismiss West Virginia patent suit over MS drug

30-06-2017

Teva and Mylan have agreed to dismiss a patent infringement dispute centring on Copaxone (glatiramer acetate), a treatment for multiple sclerosis.


Teva, Mylan, patent, dismiss, Copaxone, Natco, ANDA, FDA, patent infringement, settlement

LSIPR